Dicerna™ Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved the grant of inducement stock options to purchase a total of 29,000 shares of common stock to be distributed among four new employees, with a grant date of September 3, 2019.
September 4, 2019
· 3 min read